Kinea Bio logo

Kinea Bio jobs and careers

About Kinea Bio

Kinea Bio is a patient-focused biotechnology company striving to accelerate the development of next-generation AAV-based gene therapies to treat neuromuscular diseases. Kinea is developing an integrated technology platform designed to address the most critical challenges facing the field of gene therapy, including novel targeting and gene regulation technologies, advanced engineered tissue modeling capabilities, and strategies that will enable delivery of larger, more functional therapeutic cargos that has previously been possible.

Employees
1 to 10
Total funding
$500K

Leadership

The top of Kinea Bio's org chart, with how many people report into each leader.

MDPhoto of Martin K. Childers DO

Martin K. Childers DO

Chief Executive Officer